跳至主要内容
临床试验/IRCT20140223N115938
IRCT20140223N115938已完成未知

A comparison of Remifentanil and Labetalol infusion on intraoperative bleeding during Rhinoplasty surgery

Shiraze University of Medical Sciences ?Researh0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Inclusion:The patient with ASA 1-2 ;Men or Women between 18- 50 years; Disease without surgery Rhinoplasty;No patient had a history or physical exam of clotting problems; Blood pressure above then 100/70 mm/Hg ;Heart rate above then 40 mint;No history of Obstractive lung disease and Heart disease .
  • Exclusion criteria: Patient with ASA above 2;Men or Women with Age less then 18 years and age above then 50 years; Repeat Rhinoplasty surgery ;Coagulation problem in history and physical exam;Blood pressure less then100/70mm/Hg;Heart rate less then 40 mint;History Obstractive lung disease and any Heart disease.

排除标准

  • 未提供

研究者

发起方
Shiraze University of Medical Sciences ?Researh

相似试验